Charles Schwab Investment Management Inc Spruce Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 15,289 shares of SPRB stock, worth $7,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,289
Previous 15,289
-0.0%
Holding current value
$7,950
Previous $44,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SPRB
# of Institutions
54Shares Held
18.3MCall Options Held
49KPut Options Held
48.1K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.53 Million28.35% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.51 Million0.17% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.36 Million0.05% of portfolio
-
Abingworth LLP London, X01.79MShares$932,1090.65% of portfolio
-
Aisling Capital Management LP New York, NY1.21MShares$626,8650.33% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $12.3M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...